BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xing Y, Yan J, Niu Y. PXR: a center of transcriptional regulation in cancer. Acta Pharm Sin B 2020;10:197-206. [PMID: 32082968 DOI: 10.1016/j.apsb.2019.06.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Du L, Qi R, Wang J, Liu Z, Wu Z. Indole-3-Propionic Acid, a Functional Metabolite of Clostridium sporogenes, Promotes Muscle Tissue Development and Reduces Muscle Cell Inflammation. Int J Mol Sci 2021;22:12435. [PMID: 34830317 DOI: 10.3390/ijms222212435] [Reference Citation Analysis]
2 Bwayi MN, Garcia-Maldonado E, Chai SC, Xie B, Chodankar S, Huber AD, Wu J, Annu K, Wright WC, Lee HM, Seetharaman J, Wang J, Buchman CD, Peng J, Chen T. Molecular basis of crosstalk in nuclear receptors: heterodimerization between PXR and CAR and the implication in gene regulation. Nucleic Acids Res 2022:gkac133. [PMID: 35212371 DOI: 10.1093/nar/gkac133] [Reference Citation Analysis]
3 Creamer BA, Sloan SNB, Dennis JF, Rogers R, Spencer S, McCuen A, Persaud P, Staudinger JL. Associations between Pregnane X Receptor and Breast Cancer Growth and Progression. Cells 2020;9:E2295. [PMID: 33076284 DOI: 10.3390/cells9102295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang C, Ding S, Sun B, Shen L, Xiao L, Han Z, Huang H. Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib. Pharmacol Res 2020;161:105110. [PMID: 32755614 DOI: 10.1016/j.phrs.2020.105110] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
5 Liu J, Yang C, Huang XM, Lv PP, Yang YK, Zhao JN, Zhao SY, Sun WJ. Knockdown of FBI-1 Inhibits the Warburg Effect and Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeted Agents via miR-3692/HIF-1α. Front Oncol 2021;11:796839. [PMID: 34869045 DOI: 10.3389/fonc.2021.796839] [Reference Citation Analysis]
6 Alatshan A, Benkő S. Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function. Front Immunol 2021;12:630569. [PMID: 33717162 DOI: 10.3389/fimmu.2021.630569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhao X, Zhou J, Liang W, Sheng Q, Lu L, Chen T, Chen J, Tan K, Lv Z. Probiotics mixture reinforces barrier function to ameliorate necrotizing enterocolitis by regulating PXR-JNK pathway. Cell Biosci 2021;11:20. [PMID: 33482929 DOI: 10.1186/s13578-021-00530-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Qin M, Xin Y, Bian Y, Yang X, Xi T, Xiong J. Phosphorylation-Induced Ubiquitination and Degradation of PXR through CDK2-TRIM21 Axis. Cells 2022;11:264. [DOI: 10.3390/cells11020264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen S, Zhang L, Yuan Q, Tan J. Current Advances in Aptamer-based Biomolecular Recognition and Biological Process Regulation. Chem Res Chin Univ . [DOI: 10.1007/s40242-022-2087-9] [Reference Citation Analysis]
10 Zhang X, Xu Y, Bai Q, Li X, Han J, Hou Y, Ji Y, Zhang Z. Inhibition of LXR signaling by SULT2B1b promotes liver regeneration after partial hepatectomy in mouse models of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2020;319:G87-96. [PMID: 32475129 DOI: 10.1152/ajpgi.00380.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Niu Y, Fan S, Luo Q, Chen L, Huang D, Chang W, Qin W, Shi G. Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis. J Clin Transl Hepatol 2021;9:466-76. [PMID: 34447675 DOI: 10.14218/JCTH.2021.00036] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Strupp C, Quesnot N, Richert L, Moore J, Bomann WH, Singh P. Weight of evidence and human relevance evaluation of the benfluralin mode of action in rodents (Part I): Liver carcinogenesis. Regul Toxicol Pharmacol 2020;117:104758. [PMID: 32798612 DOI: 10.1016/j.yrtph.2020.104758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Du Y, Shi X, Ma W, Wen P, Yu P, Wang X, Fang P, Chen A, Gao Z, Cui K. Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1. Pharmacol Res 2021;169:105648. [PMID: 33965509 DOI: 10.1016/j.phrs.2021.105648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Shao M, Lu L, Wang Q, Ma L, Tian X, Li C, Li C, Guo D, Wang Q, Wang W, Wang Y. The multi-faceted role of retinoid X receptor in cardiovascular diseases. Biomed Pharmacother 2021;137:111264. [PMID: 33761589 DOI: 10.1016/j.biopha.2021.111264] [Reference Citation Analysis]
15 Skandalaki A, Sarantis P, Theocharis S. Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment. Biomolecules 2021;11:1142. [PMID: 34439808 DOI: 10.3390/biom11081142] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mustonen E, Pantsar T, Rashidian A, Reiner J, Schwab M, Laufer S, Burk O. Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library. Cells 2022;11:1299. [DOI: 10.3390/cells11081299] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Theocharis S, Giaginis C, Gourzi S, Alexandrou P, Tsourouflis G, Sarantis P, Danas E, Michail A, Tsoukalas N, Pergaris A, Politis PK, Nakopoulou L. High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma. Diagnostics (Basel) 2021;11:1946. [PMID: 34829293 DOI: 10.3390/diagnostics11111946] [Reference Citation Analysis]
18 Sheng W, Ji G, Zhang L. The Effect of Lithocholic Acid on the Gut-Liver Axis. Front Pharmacol 2022;13:910493. [DOI: 10.3389/fphar.2022.910493] [Reference Citation Analysis]
19 Luan ZL, Zhang C, Ming WH, Huang YZ, Guan YF, Zhang XY. Nuclear receptors in renal health and disease. EBioMedicine 2022;76:103855. [PMID: 35123268 DOI: 10.1016/j.ebiom.2022.103855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Smutny T, Hyrsova L, Braeuning A, Ingelman-Sundberg M, Pavek P. Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism. Arch Toxicol 2021;95:11-25. [PMID: 33164107 DOI: 10.1007/s00204-020-02916-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Burk O, Kronenberger T, Keminer O, Lee SML, Schiergens TS, Schwab M, Windshügel B. Nelfinavir and Its Active Metabolite M8 Are Partial Agonists and Competitive Antagonists of the Human Pregnane X Receptor. Mol Pharmacol 2021;99:184-96. [PMID: 33483427 DOI: 10.1124/molpharm.120.000116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Caliceti C, Punzo A, Silla A, Simoni P, Roda G, Hrelia S. New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer. Nutrients 2022;14:2964. [DOI: 10.3390/nu14142964] [Reference Citation Analysis]
23 Jiang Q, Ma Y, Han J, Chu J, Ma X, Shen L, Liu B, Li BA, Hou J, Bi Q. MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor. Front Oncol 2021;11:715193. [PMID: 34249768 DOI: 10.3389/fonc.2021.715193] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zemanová N, Anzenbacher P, Zapletalová I, Jourová L, Hermanová P, Hudcovic T, Kozáková H, Vodička M, Pácha J, Anzenbacherová E. The role of the microbiome and psychosocial stress in the expression and activity of drug metabolizing enzymes in mice. Sci Rep 2020;10:8529. [PMID: 32444678 DOI: 10.1038/s41598-020-65595-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang RX, Dong K, Wang Z, Miao R, Lu W, Wu XY. Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine. Pharmaceutics 2021;13:1261. [PMID: 34452222 DOI: 10.3390/pharmaceutics13081261] [Reference Citation Analysis]
26 Alghamdi MA, Fallica AN, Virzì N, Kesharwani P, Pittalà V, Greish K. The Promise of Nanotechnology in Personalized Medicine. JPM 2022;12:673. [DOI: 10.3390/jpm12050673] [Reference Citation Analysis]
27 Sayaf K, Zanotto I, Russo FP, Gabbia D, De Martin S. The Nuclear Receptor PXR in Chronic Liver Disease. Cells 2021;11:61. [PMID: 35011625 DOI: 10.3390/cells11010061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Daujat-Chavanieu M, Gerbal-Chaloin S. Regulation of CAR and PXR Expression in Health and Disease. Cells 2020;9:E2395. [PMID: 33142929 DOI: 10.3390/cells9112395] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
29 Wang J, Bwayi M, Gee RRF, Chen T. PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches. Expert Opin Drug Metab Toxicol 2020;16:711-22. [PMID: 32500752 DOI: 10.1080/17425255.2020.1779701] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Zhang YF, Gao Y, Yang J, Jiang YM, Huang M, Fan SC, Bi HC. Long-term treatment with the mPXR agonist PCN promotes hepatomegaly and lipid accumulation without hepatocyte proliferation in mice. Acta Pharmacol Sin 2022. [PMID: 35773338 DOI: 10.1038/s41401-022-00925-3] [Reference Citation Analysis]